Hong Kong Pharmaceuticals and Healthcare Report Q4 2014

Date: August 27, 2014
Pages: 114
Price:
US$ 1,295.00
Publisher: Business Monitor International
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: H1C2EC1410FEN
Leaflet:

Download PDF Leaflet

Includes 3 FREE quarterly updates

BMI View: Hong Kong will remain as an attractive destination for foreign pharmaceutical firms due to rising medical demands from the ageing population. In addition, its proximity from China will also allow companies to expand into the world's largest emerging market.

Headline Expenditure Projections
  • Pharmaceuticals: HKD11.24bn (USD1.45bn) in 2013 to HKD12.12bn (USD1.56bn) in 2014; +7.8% in local currency terms and US dollar terms. Forecast broadly in line with Q314.
  • Healthcare: HKD122.00bn (USD15.73bn) in 2013 to HKD130.97bn (USD16.85bn) in 2014; +7.3% in local currency terms and US dollar terms. Forecast broadly in line with Q314.
BMI Industry View
SWOT
Political
Economic
Business Environment
Industry Forecast
Pharmaceutical Market Forecast
  Table: Pharmaceutical Sales, Historical Data And Forecasts (Hong Kong 2010-2018)
Healthcare Market Forecast
  Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2010-2018)
  Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2010-2018)
  Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Hong Kong 2010-2018)
Prescription Drug Market Forecast
  Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2010-2018)
Patented Drug Market Forecast
  Table: Patented Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2010-2018)
Generic Drug Market Forecast
  Table: Generic Drug Market Indicators, Historical Data And Forecasts (Hong Kong 2010-2018)
Hong Kong
  Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Hong Kong 2010-2018)
Pharmaceutical Trade Forecast
  Table: Pharmaceutical Trade Data And Forecasts (Hong Kong 2012-2018)
  Table: Pharmaceutical Trade Data And Forecasts local currency (Hong Kong 2012-2018)
Other Healthcare Data
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
External Trade Not What It Seems
Property Correction Informs Below Consensus Forecast
Expenditure Breakdown
  Table: Hong Kong - Economic Activity
Industry Risk Reward Ratings
Asia Pacific Risk/Reward Ratings
Hong Kong Risk/Reward Ratings
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
  Table: Top Causes Of Death In Hong Kong
Healthcare Sector
Healthcare Financing
Healthcare Insurance
Biotechnology
Clinical Trials
Regulatory Development
Regulatory Regime
  Table: Processed Applications
Regulatory Developments
Pharmaceutical Trade Regulations
Intellectual Property Issues
Counterfeit Drugs
Pricing And Reimbursement Regime
  Table: Number Of Drugs In Drug Formulary
Competitive Landscape
Pharmaceutical Industry
Traditional Chinese Medicine
Industry Developments
Pharmaceutical Supply Chain
Retail Pharmacy Sector
Company Profile
Wuyi International Pharmaceutical
CK Life Sciences
South Asia Pharmamedic
C&Y Pharmaceutical Investment
Vida Laboratories
GlaxoSmithKline
Pfizer
Sanofi
Merck & Co
Novartis
Demographic Forecast
  Table: Hong Kong's Population By Age Group, 1990-2020 ('000)
  Table: Hong Kong's Population By Age Group, 1990-2020 (% of total)
  Table: Hong Kong's Key Population Ratios, 1990-2020
  Table: Hong Kong's Rural And Urban Population, 1990-2020
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Ratings Methodology
Ratings Overview
  Table: Pharmaceutical Risk/Reward Ratings Indicators
Indicator Weightings
Hong Kong Pharmaceuticals and Healthcare Report Q1 2015 US$ 1,295.00 Nov, 2014 · 113 pages
Hong Kong Pharmaceuticals and Healthcare Report Q2 2014 US$ 1,295.00 Feb, 2014 · 113 pages
Hong Kong Pharmaceuticals and Healthcare Report Q3 2014 US$ 1,295.00 May, 2014 · 114 pages
OTC Healthcare in Hong Kong to 2014 US$ 495.00 Jul, 2010 · 189 pages
Pet Healthcare Market in Hong Kong to 2014 US$ 495.00 Mar, 2011 · 153 pages

Ask Your Question

Hong Kong Pharmaceuticals and Healthcare Report Q4 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: